Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,345.20
(
3.40%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
92.62
(
-8.49%
)
Bitcoin
71,640.27
(
-0.48%
)
News Focus
News Focus
Post# of 704041
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mlsoft

Send PM Follow Ignore
Followers 113
Posts 13225
Boards Moderated 0
Alias Born 07/07/2002

mlsoft

Member Level

Re: Paul A post# 101647

Friday, 04/25/2003 2:08:44 PM

Friday, April 25, 2003 2:08:44 PM

Post# of 704041
Paul...

I haven't added to ICN today - probably will not do so unless it breaks $9. It is disappointing that all these companies are doubling by issuing PR's that they are working on SARS (it could be years, if ever, before one of them are successful) while the only drug that the World Health Organization says has been effective in the treatment of the disease (ICN's ribavirin) has been ignored. I think ICN could use a little PR at the moment to help get the word out.

mlsoft
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today